INCUBATION THE IDEA SUBMISSION PORTAL FROM MEDTRONIC
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
After a detailed evaluation based on technical, operational and strategic criteria, selected projects may proceed to a testing phase. Medtronic Eureka testing phase is a key process step: the primary objectives of testing are to demonstrate feasibility and therapy effectiveness.
Medtronic initiates the test phase by assigning an expert project team to assess the selected submitted ideas’ feasibility, and model or prototype the idea. For each selected project, the experts’ focus is upon determining proof of concept and elimination or mitigation of the most significant risks during the testing process.
In simple terms, prototyping moves the invention from a virtual concept into a physical implementation.
Depending on the invention, a prototype may or may not be necessary -- or only portions of the submitted idea may need prototyping. Regardless of the method used, prototyping and modeling are essential for learning, visualization, and idea validation.
The submitter may or may not need to be involved during the testing phase.
If the submitter is involved in collaboration with Medtronic for prototyping of his submission, a Prototype Development Agreement is established between both parties to agree on the scope of the collaboration, the roles and responsibilities and on intellectual property derived in the testing phase.